By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Biotechnology Industry Organization (BIO) 

1225 Eye Street, NW
Suite 400
Washington  D.C.  20005-5958  U.S.A.
Phone: 202-962-9200 Fax: 202-962-9201


SEARCH JOBS

The Biotechnology Industry Organization (BIO) is the largest trade organization to serve and represent the emerging biotechnology industry in the United States and around the globe. The organization's leadership and service-oriented guidance have helped advance the industry and bring the benefits of biotechnology to the people of the world.

As the leading voice for the biotechnology industry, BIO represents companies of all sizes engaged in the development of products and services in the areas of agriculture, biomedicine, diagnostics, food, energy and environmental applications. Though biotechnology's future is bright, the industry's success will depend on the commitment, energy and direction of the group that helps guide its growth. BIO is a vital forum and an invaluable focal point to bring together the resources and expertise to meet critical challenges and serve the needs of its members.

Key Statistics


Email: info@bio.org
Ownership: Private

Web Site: BIO
Employees:
Symbol: 
 





Collaborations

CHI 





Company News
BIO Thanks Senators For Supporting Higher RFS Volumes 6/24/2016 1:58:17 PM
BIO Welcomes Senate Agreement On GMO Labeling 6/24/2016 8:33:22 AM
BIO2016: The Coalition of State Bioscience Institutes (CSBI) Releases The 2016 Life Sciences Workforce Trends Report At BIO 6/10/2016 10:28:42 AM
BIO2016: The 2016 BIO International Convention Closes In San Francisco - Event Sets New Record For Partnering Meetings 6/10/2016 8:21:10 AM
BIO2016: French Firm Biose to Open U.S. HQ in Cambridge to Look for Partners 6/10/2016 6:39:02 AM
BIO2016: Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At BIO International Convention To Provide Updates On Actimab-A And Iomab-B Programs 6/9/2016 12:31:45 PM
BIO Release: New Report Shares Best Practices For The Development Of Disease-Specific Patient Preference Studies 6/9/2016 10:51:08 AM
BIO Release: Missouri Governor Nixon Signs Bill Ensuring Patient Access To Interchangeable Biologic Medicines 6/9/2016 10:42:43 AM
BIO2016: The State of the Biotech Innovation and Drivers of Forecasting Success 6/9/2016 8:31:22 AM
BIO2016: DiaMedica Looks to Woo Potential Partners, Investors for Ischemic Stroke Drug at Conference 6/9/2016 8:02:20 AM
12345678910...
//-->